During the 70s and 80s, I spent my after-school hours at my uncle's drugstore and watched him counsel farmers and General Motors workers on their ailments, giving personalized advice that went far beyond just filling prescriptions. That small-town pharmacy taught me what healthcare should be: accessible, personal, and focused on finding solutions that actually work  for people's lives. Forty years into my career as a pharmacist, I still get asked that same question by family,

U.S. prescription drug spending reached $806 billion in 2024 —a $50 billion jump and a 10.2% year-over-year increase . High-cost categories like GLP-1s and oncology therapies are driving much of the growth, and health plans are feeling the pressure from all sides. Member groups are demanding more support, better transparency, and relief from cost surprises. The question most plans are asking isn't whether to act—it's how to act without starting from zero. The Shift: From Mono

By Chris Crawford, Founder of RxSaveCard Prescription drug costs—especially GLP-1s and specialty medications—are overwhelming...